Open original FDA record ↗Recall record
- FDA identifier
- Z-1835-2016
- Company in FDA record
- Pentax Medical Company
- FDA record creation date
- May 27, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Pentax Medical learned of reports of carbapenem-resistant Enterobacteriaceae (CRE) infection at a medical facility.
Source facts
- Action
- Pentax Inc. issued an "Urgent Field Correction" Letter dated February 19, 2016, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The letter provides information regarding the updated Reprocessing instruction for use along with some main changes in the Operation IFU. Instructions are also provided regarding prior versions of the Reprocessing and Operation Instructions for Use. A web posting went live on 2/19/2016. For further questions, please call: Tel:800-431-5880 ext. 2064 (8:30AM- 5:00 PM, Monday-Friday, EST)
- Initiated
- 2016-02-22
- Root cause
- Other
- Terminated
- 2017-12-06
- Distribution
- Nationwide
- Recall number
- Z-1835-2016
- Recall status
- Terminated
- CDRH record ID
- 143988
- FDA record created
- 2016-05-27
- Recall event number
- 73377